SWS Medical(688410.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
SWS Medical
688410.SH
SWS Hemodialysis Care Co., Ltd. provides integrated blood purification solutions for renal failure and critically ill patients internationally. It offers blood purification consumables, chain hemodialysis center medical services, dialysis disposables, and a dialysis center intelligent management system, as well as operates chain dialysis centers. The company also offers blood purification equipment, which includes continuous blood purification equipment, hemodialysis machines, hemoperfusion machines and others.
955.39 B
688410.SHMarket value -Rank by Market Cap -/-

Financial Score

24/01/2026 Update
B
Health Care EquipmentIndustry
Industry Ranking20/64
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.55%C
    • Profit Margin15.46%A
    • Gross Margin50.86%B
  • Growth ScoreA
    • Revenue YoY37.78%A
    • Net Profit YoY51.60%B
    • Total Assets YoY12.70%B
    • Net Assets YoY4.41%C
  • Cash ScoreB
    • Cash Flow Margin646.73%C
    • OCF YoY37.78%A
  • Operating ScoreD
    • Turnover0.36D
  • Debt ScoreA
    • Gearing Ratio18.91%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    20:00 ET El líder de la industria de diálisis de China presentará soluciones de vanguardia en MEDICA 2025

    SWS Medical, a leading Chinese provider of blood purification solutions, will showcase its innovative products at MEDICA 2025 in Düsseldorf, Germany. With over 20 years of experience, SWS is the top Chinese exporter of dialysis equipment, holding significant market shares in China. At MEDICA, SWS will present advanced dialysis technologies, including the SWS-6000 and SWS-5000 models, and its comprehensive range of products designed to improve treatment outcomes and workflow efficiency.

    prnewswire·
    SH
    688410
    +1.54%
    prnewswire·
    SH
    688410
    +1.54%

    "Artificial Intelligence + Healthcare" welcomes new policies, multiple listed companies are expected to benefit

    On November 4th, the National Health Commission issued the "Implementation Opinions on Promoting and Regulating the Development of 'Artificial Intelligence + Healthcare' Applications." Several A-share companies, such as SWS Medical, Yunnan Baiyao, and EASEPAL, have already laid out plans in the "Artificial Intelligence + Healthcare" field. The implementation opinions clarify the direction of industry support and key application areas, bringing new business expansion opportunities to related listed companies and aiding in performance growth

    Wallstreetcn·
    SZ
    000538
    -0.88%
    SZ
    002614
    -1.77%
    SH
    688410
    +1.54%
    Wallstreetcn·
    SZ
    000538
    -0.88%
    SZ
    002614
    -1.77%
    SH
    688410
    +1.54%

    SWS Medical: Net profit for the third quarter was 49.4488 million yuan, a year-on-year increase of 205.50%

    SWS Medical announced that its revenue for the third quarter was 227 million yuan, a year-on-year increase of 61.66%; net profit was 49.448 million yuan, a year-on-year increase of 205.50%. Revenue for the first three quarters was 584 million yuan, a year-on-year increase of 39.79%; net profit was 104 million yuan, a year-on-year increase of 68.68%

    Zhitong·
    SH
    688410
    +1.54%
    Zhitong·
    SH
    688410
    +1.54%

    SWS Medical shareholders plan to reduce their holdings by no more than 4.08%

    SWS Medical announced that its shareholder, Dajiankang, intends to reduce its holdings by no more than 12.8526 million shares, accounting for no more than 4%. The director and deputy general manager, Ren Yingxiang, intends to reduce his holdings by no more than 249,500 shares, accounting for no more than 0.08%

    Zhitong·
    SH
    688410
    +1.54%
    Zhitong·
    SH
    688410
    +1.54%

    SWS Medical: Net profit for the first half of the year was 55.0386 million yuan, a year-on-year increase of 20.28%

    On the evening of August 19th, SWS Medical disclosed its 2025 semi-annual report, showing that the company achieved operating revenue of 357 million yuan in the first half of the year, a year-on-year increase of 28.72%; the net profit attributable to the parent company was 55.0386 million yuan, a year-on-year increase of 20.28%. The basic earnings per share were 0.1713 yuan. During the reporting period, the company's product market share continued to increase, driving steady growth in sales revenue of blood purification equipment; the sales revenue of self-produced blood purification consumables saw a significant increase

    Zhitong·
    SH
    688410
    +1.54%
    Zhitong·
    SH
    688410
    +1.54%
    © 2026 Longbridge｜Disclaimer